MNOV

$0.00

(

0.00%

)
Quote details

stock

MediciNova Inc

NASDAQ | MNOV

1.24

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$61.80M

Market Cap

-

P/E Ratio

-0.25

EPS

$2.54

52 Week High

$1.12

52 Week Low

HEALTHCARE

Sector

MNOV Chart

Recent Chart
Price Action

MNOV Technicals

Tags:

MNOV Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$21K
Total Revenue $0
Cost Of Revenue $21K
Costof Goods And Services Sold $21K
Operating Income -$13M
Selling General And Administrative $5.2M
Research And Development $7.2M
Operating Expenses $13M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $1.7M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $21K
Income Before Tax -$11M
Income Tax Expense $5.5K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$11M

Revenue & Profitability

Earnings Performance

MNOV Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $56M
Total Current Assets $41M
Cash And Cash Equivalents At Carrying Value $40M
Cash And Short Term Investments $40M
Inventory -
Current Net Receivables -
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $4.8M
Intangible Assets Excluding Goodwill $4.8M
Goodwill $9.6M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $715K
Other Non Current Assets -
Total Liabilities $3.4M
Total Current Liabilities $3M
Current Accounts Payable $1.1M
Deferred Revenue -
Current Debt -
Short Term Debt $388K
Total Non Current Liabilities $413K
Capital Lease Obligations $194K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $194K
Other Current Liabilities $1.5M
Other Non Current Liabilities $211K
Total Shareholder Equity $53M
Treasury Stock -
Retained Earnings -$427M
Common Stock $49K
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$11M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $21K
Capital Expenditures $895
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$697
Cashflow From Financing -
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$11M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$21K
Total Revenue $0
Cost Of Revenue $21K
Costof Goods And Services Sold $21K
Operating Income -$13M
Selling General And Administrative $5.2M
Research And Development $7.2M
Operating Expenses $13M
Investment Income Net -
Net Interest Income $1.7M
Interest Income $1.7M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $21K
Income Before Tax -$11M
Income Tax Expense $5.5K
Interest And Debt Expense -
Net Income From Continuing Operations -$11M
Comprehensive Income Net Of Tax -
Ebit -$11M
Ebitda -$11M
Net Income -$11M

MNOV News

MNOV Profile

MediciNova Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

MediciNova, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, dedicated to advancing innovative small molecule therapies aimed at addressing serious diseases with significant unmet medical needs. The company’s pipeline includes promising candidates for conditions such as respiratory disorders and neurological diseases, leveraging its expertise in drug development to improve patient outcomes. MediciNova is strategically positioned to make impactful contributions to the healthcare landscape while also pursuing robust partnerships to accelerate its product development initiatives.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
PLUG
+14.03%
$3.90
INTC
-3.78%
$36.36
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.